Skip to content
10-Q

Quarterly Report

ARALEZ PHARMACEUTICALS INC.

0001558370-18-004351

← back to feed
Filed
May 8, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 4, 2018 67.19M sh
Shares Diluted Q1 2018 · Mar 31, 2018 67.03M sh
Shares Diluted Q1 2018 · Mar 31, 2017 65.69M sh
Capex Q1 2018 · Mar 31, 2018 $32K
Capex Q1 2018 · Mar 31, 2017 $1.46M
Operating Cash Flow Q1 2018 · Mar 31, 2018 $18.58M
Operating Cash Flow Q1 2018 · Dec 31, 2017 −$28.8M
Operating Cash Flow Q1 2018 · Mar 31, 2017 $10.49M
Long Term Debt Q1 2018 · Mar 31, 2018 $274.57M
Long Term Debt Q1 2018 · Dec 31, 2017 $274.55M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $43.89M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $28.89M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $73.73M
Cash And Equivalents Q1 2018 · Dec 31, 2016 $64.94M
Stockholders Equity Q1 2018 · Mar 31, 2018 −$6.58M
Stockholders Equity Q1 2018 · Dec 31, 2017 $15.22M
Current Liabilities Q1 2018 · Mar 31, 2018 $116.82M
Current Liabilities Q1 2018 · Dec 31, 2017 $67.86M
Total Liabilities Q1 2018 · Mar 31, 2018 $487.76M
Total Liabilities Q1 2018 · Dec 31, 2017 $438.26M
Current Assets Q1 2018 · Mar 31, 2018 $93.31M
Current Assets Q1 2018 · Dec 31, 2017 $52.68M
Total Assets Q1 2018 · Mar 31, 2018 $481.18M
Total Assets Q1 2018 · Dec 31, 2017 $453.48M
Eps Diluted Q1 2018 · Mar 31, 2018 −$0.29
Eps Diluted Q1 2018 · Mar 31, 2017 −$0.42
Eps Basic Q1 2018 · Mar 31, 2018 −$0.29
Eps Basic Q1 2018 · Mar 31, 2017 −$0.42
Sga Expense Q1 2018 · Mar 31, 2018 $26.5M
Sga Expense Q1 2018 · Mar 31, 2017 $30.85M
Rd Expense Q1 2018 · Mar 31, 2018 $37K
Rd Expense Q1 2018 · Mar 31, 2017 $94K
Net Income Q1 2018 · Mar 31, 2018 −$19.74M
Net Income Q1 2018 · Dec 31, 2017 −$125.2M
Net Income Q1 2018 · Mar 31, 2017 −$27.48M
Operating Income Q1 2018 · Mar 31, 2018 −$14.07M
Operating Income Q1 2018 · Mar 31, 2017 −$20.68M
Revenue Q1 2018 · Mar 31, 2018 $38.08M
Revenue Q1 2018 · Mar 31, 2017 $25.97M